Market Overview
ECMO systems temporarily take over the function of the heart and/or lungs, allowing these organs to rest and recover during severe conditions such as cardiac failure, pulmonary embolism, or acute respiratory distress syndrome. The global market encompasses ECMO machines, pumps, oxygenators, and related consumables used in hospital intensive care and cardiac surgery settings.
- •Market valued at approximately $0.58 billion in 2025, with projected growth to around $952 million by 2035 at a 5% CAGR
- •Used primarily in intensive care units and cardiac surgery centers for patients with severe cardiopulmonary failure
- •Product categories include ECMO machines, pumps, oxygenators, and associated disposables
Growth Drivers
The increasing global prevalence of cardiovascular diseases and respiratory disorders is a major catalyst for ECMO adoption. Rising numbers of complex cardiac surgeries, including transplants and congenital defect repairs, further expand demand for extracorporeal life support technologies.
- •Growing elderly population with higher incidence of heart and lung conditions
- •Increasing volume of surgical procedures requiring cardiopulmonary support
- •Expanding critical care infrastructure in both developed and emerging markets
- •Advancements in ECMO technology improving portability and reducing complications
Segmentation and Regional Analysis
The ECMO market is typically segmented by product type, including ECMO machines, oxygenators, pumps, and consumables. By patient type, applications span both neonatal, pediatric, and adult populations, with adult cardiothoracic surgery and cardiogenic shock representing the largest segments.
- •North America leads the global market, supported by advanced healthcare infrastructure and high procedure volumes
- •Europe follows as a major market, with strong adoption in countries with established critical care networks
- •Asia-Pacific is the fastest-growing region, driven by improving healthcare access and rising demand in China, India, and Southeast Asian nations
Trends and Outlook
What are the recent trends and outlook?
Ongoing trends point toward miniaturization of ECMO systems, improved biocompatible materials, and the development of portable configurations that expand use beyond traditional ICU settings. As clinical evidence supporting ECMO efficacy grows and healthcare systems prioritize advanced life-support capabilities, the market is expected to maintain steady expansion through 2035.
- •Development of portable and compact ECMO systems enabling greater clinical flexibility
- •Growing adoption of ECMO in ambulatory and transport settings as technology evolves
- •Increased focus on reducing bleeding and thrombotic complications through advanced circuit designs
- •Long-term outlook remains positive with consistent demand from aging demographics and critical care expansion
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.